The Future of Pharmaceuticals

What if there were enough medicines for everyone in the world, and people could afford them? The fourth and final episode of the EloTalk season will deep dive into the manufacturing of medicines. How can we ensure a sustainable pharmaceutical industry to secure affordable medicine for all?

Top Speakers of the Episode

Mona Åkerholm

Mona Åkerholm

Senior Vice President,
Pharma BU, Elomatic

It’s time for the pharma sector to think more sustainably.

Miroslav Tonovski

Miroslav Tonovski

CEO,
Naya Life Sciences

Transforming contamination control practices for a sustainable future of pharma facilities.

Hosted by Anna Ståhle

Anna Ståhle

Anna Ståhle is the founder of Ground, a visionary who has experienced the professional realms of media, communication, and marketing. Anna focuses on strategic planning in communication, marketing, and corporate partnerships, along with providing management consultation. She served as the chairperson of ProCom ry, Finland’s leading professional organization for communication experts, from 2008 to 2011. With a career spanning nearly two decades, Anna has worked within the media as well as the fields of communication and marketing. Her strengths lie in moderating events, possessing robust subject expertise and thorough background research, maintaining a natural and authentic style, smoothly conducting panels and interviews, and exhibiting language proficiency.

Service
Pharma

We offer strong expertise in pharmaceutical and medical device production suites.

We help you in designing, constructing, and qualifying new facilities and production lines. Our services encompass all investment phases, from creating a concept to delivering the final report.

Service
Production processes

Pharmaceuticals are produced in a variety of ways, depending on the medicine itself and the desired product. We have extensive experience and expertise in a wide range of production processes.

You can rely on our experience: we have designed several facilities with GMP approvals from the EU, FDA and local authorities.